- Präsentationen
- Dokumente
- Infografiken
Emerging Markets
guestbaefb5
•
Vor 15 Jahren
Six sigma
Ayush Mathur
•
Vor 7 Jahren
Regulatory Affairs.
Naila Kanwal
•
Vor 8 Jahren
Validation master plan
Dr. Amsavel A
•
Vor 5 Jahren
Concept of URS,DQ,IQ,OQ,PQ
dhavalrock24
•
Vor 10 Jahren
Pharmaceutical Quality by Design (QbD)
Md. Zakaria Faruki
•
Vor 5 Jahren
Committee for orphan medicinal products
EURORDIS Rare Diseases Europe
•
Vor 6 Jahren
Cmc postapproval regulatory affairs (ppt)
suresh gautam
•
Vor 5 Jahren
Canada’s Orphan Drug Regulatory Framework & panCanadian Access to Rare Disease Drugs: Updated and Opportunities
Canadian Organization for Rare Disorders
•
Vor 8 Jahren
Canada’s Orphan Drug Regulatory Framework: What Health Canada is doing now and what is yet to come : Liz-Anne Gillham-Eisen (Health Canada)
Canadian Organization for Rare Disorders
•
Vor 7 Jahren
Update: National Plans for Rare Diseases
Canadian Organization for Rare Disorders
•
Vor 9 Jahren
Submitting electronic Drug Master Files (DMF) and Active Substance Master Files (ASMF)
eCTDconsultancy
•
Vor 6 Jahren
Drug master file
Bindu Kshtriya
•
Vor 7 Jahren
ORPHAN DRUGS- ACTS, PAST AND CURRENT SCENARIO, WITH UPCOMING DRUGS
Ashish Bajaj
•
Vor 9 Jahren
Regulatory requirements for orphan drugs delivery
Prof. Dr. Basavaraj Nanjwade
•
Vor 9 Jahren
Orphan drugs presentation
Atul Rajpara
•
Vor 8 Jahren
Orphan Drugs
ANCY JOSE
•
Vor 9 Jahren
Premarket Notification The 510(k) Process
Michael Swit
•
Vor 6 Jahren
QUALITY SYSTEM REQUIREMENTS FOR NATIONAL GMP INSPECTORATES
vasanthi chodavarapu
•
Vor 7 Jahren
INSPECTION OF DRUG DISTRIBUTION CHANNELS
OORATHI SASIVARDHAN
•
Vor 7 Jahren